Entry
Name
MicroRNAs in cancer
Description
MicroRNA (miRNA) is a cluster of small non-encoding RNA molecules of 21 - 23 nucleotides in length, which controls gene expression post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein translation. Using high-throughput profiling, dysregulation of miRNAs has been widely observed in different stages of cancer. The upregulation (overexpression) of specific miRNAs could lead to the repression of tumor suppressor gene expression, and conversely the downregulation of specific miRNAs could result in an increase of oncogene expression; both these situations induce subsequent malignant effects on cell proliferation, differentiation, and apoptosis that lead to tumor growth and progress. The miRNA signatures of cancer observed in various studies differ significantly. These inconsistencies occur due to the differences in the study populations and methodologies used. This pathway map shows the summarized results from various studies in 9 cancers, each of which is presented in a review article.
Class
Human Diseases; Cancer: overview
BRITE hierarchy
Pathway map
Orthology
K00312 WNT3; wingless-type MMTV integration site family, member 3
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153 ]
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11 ]
K02085 APC; adenomatosis polyposis coli protein
K02161 BCL2; apoptosis regulator Bcl-2
K02163 BCLW; apoptosis regulator BCL-W
K02539 MCL1; myeloid leukemia cell differntiation protein MCL-1
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K04359 PDGFA; platelet-derived growth factor subunit A
K04363 PDGFRA, CD140A; platelet-derived growth factor receptor alpha [EC:2.7.10.1 ]
K04364 GRB2; growth factor receptor-bound protein 2
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1 ]
K04368 MAP2K1, MEK1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2 ]
K04369 MAP2K2, MEK2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2 ]
K04377 MYC; Myc proto-oncogene protein
K04438 CRK, CRKII; C-crk adapter molecule crk
K04445 RPS6KA5, MSK1; ribosomal protein S6 kinase alpha-5 [EC:2.7.11.1 ]
K04451 TP53, P53; tumor protein p53
K04503 CCND1; G1/S-specific cyclin-D1
K04513 RHOA; Ras homolog gene family, member A
K04692 STAT3; signal transducer and activator of transcription 3
K04694 SOCS1, JAB; suppressor of cytokine signaling 1
K04702 PIM1; proto-oncogene serine/threonine-protein kinase Pim-1 [EC:2.7.11.1 ]
K05083 ERBB2, HER2, CD340; receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1 ]
K05084 ERBB3, HER3; receptor tyrosine-protein kinase erbB-3 [EC:2.7.10.1 ]
K05089 PDGFRB, CD140B; platelet-derived growth factor receptor beta [EC:2.7.10.1 ]
K05094 FGFR3, CD333; fibroblast growth factor receptor 3 [EC:2.7.10.1 ]
K05099 MET, HGFR; proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1 ]
K05448 VEGFA; vascular endothelial growth factor A
K05658 ABCB1, CD243; ATP-binding cassette, subfamily B (MDR/TAP), member 1 [EC:7.6.2.2 ]
K05665 ABCC1; ATP-binding cassette, subfamily C (CFTR/MRP), member 1 [EC:7.6.2.3 ]
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11 ]
K06279 SHC1; SHC-transforming protein 1
K06484 ITGA5, CD49e; integrin alpha 5
K06493 ITGB3, CD61; integrin beta 3
K06620 E2F3; transcription factor E2F3
K06621 CDKN2A, P16, INK4A; cyclin-dependent kinase inhibitor 2A
K06624 CDKN1B, P27, KIP1; cyclin-dependent kinase inhibitor 1B
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
K06626 CCNE; G1/S-specific cyclin-E1
K07187 IRS2; insulin receptor substrate 2
K07203 MTOR, FRAP, TOR; serine/threonine-protein kinase mTOR [EC:2.7.11.1 ]
K07204 RAPTOR; regulatory associated protein of mTOR
K07209 IKBKB, IKKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10 ]
K07827 KRAS, KRAS2; GTPase KRas
K07996 MMP16; matrix metalloproteinase-16 (membrane-inserted) [EC:3.4.24.-]
K08270 DDIT4, REDD1; DNA-damage-inducible transcript 4
K09283 HMGA2; high mobility group AT-hook protein 2
K09295 HOXD10; homrobox protein Hox-D10
K09299 ZEB1; zinc finger homeobox protein 1
K09389 E2F2; transcription factor E2F2
K09850 RASSF1; Ras association domain-containing protein 1
K10127 MDM4, MDMX; protein Mdm4
K10149 TP63; tumor protein p63
K10151 CCND2; G1/S-specific cyclin-D2
K10577 UBE2I, UBC9; ubiquitin-conjugating enzyme E2 I
K10605 BRCA1; breast cancer type 1 susceptibility protein [EC:2.3.2.27 ]
K11411 SIRT1, SIR2L1; NAD-dependent protein deacetylase sirtuin 1 [EC:2.3.1.286 ]
K11430 EZH2; [histone H3]-lysine27 N-trimethyltransferase EZH2 [EC:2.1.1.356 ]
K11459 PCGF4, BMI1; polycomb group RING finger protein 4
K11592 DICER1, DCR1; endoribonuclease Dicer [EC:3.1.26.-]
K12561 MARCKS; myristoylated alanine-rich C-kinase substrate
K12886 HNRNPK; heterogeneous nuclear ribonucleoprotein K
K13376 TGFB2; transforming growth factor beta-2
K13863 SLC7A1, ATRC1; solute carrier family 7 (cationic amino acid transporter), member 1
K14021 BAK, BAK1; Bcl-2 homologous antagonist/killer
K15379 SLC45A3; solute carrier family 45, member 3
K16172 IRS1; insulin receptor substrate 1
K16341 BCL2L11, BIM; Bcl-2-like protein 11
K16857 THBS1; thrombospondin 1
K16865 PDCD4; programmed cell death protein 4
K16866 TIMP3; metalloproteinase inhibitor 3
K16980 MIRLET7; microRNA let-7
K17110 MIR30A_D_E; microRNA 30a/d/e
K17383 SPRY2; protein sprouty homolog 2
K17386 PDGFB; platelet-derived growth factor subunit B
K17387 KIF23; kinesin family member 23
K17391 IGF2BP1; insulin-like growth factor 2 mRNA-binding protein 1
K17397 MIRLET7C; microRNA let-7c
K17442 ZFPM2, FOG2; zinc finger protein ZFPM2
K17449 SHC4; SHC-transforming protein 4
K17454 E2F1; transcription factor E2F1
K17460 BMF; Bcl-2-modifying factor
K17461 RECK, ST15; reversion-inducing-cysteine-rich protein with kazal motifs
K23560 ZEB2; zinc finger homeobox protein 2
K23581 SOX4; transcription factor SOX4 (SOX group C)
K23582 FOXP1; forkhead box protein P1
Reference
Authors
Lee YS, Dutta A
Title
MicroRNAs in cancer.
Journal
Reference
Authors
Babashah S, Soleimani M
Title
The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
Journal
Reference
Authors
Garzon R, Calin GA, Croce CM
Title
MicroRNAs in Cancer.
Journal
Reference
Authors
Chen PS, Su JL, Hung MC
Title
Dysregulation of microRNAs in cancer.
Journal
Reference
Authors
Ling H, Zhang W, Calin GA
Title
Principles of microRNA involvement in human cancers.
Journal
Reference
Authors
Iorio MV, Croce CM
Title
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.
Journal
Reference
Authors
Sayed D, Abdellatif M
Title
MicroRNAs in development and disease.
Journal
Reference
Authors
Wang Q, Wang S, Wang H, Li P, Ma Z
Title
MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.
Journal
Reference
Authors
Song JH, Meltzer SJ
Title
MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
Journal
Reference
Authors
Chu Y, Zhu H, Lv L, Zhou Y, Huo J
Title
MiRNA s in oesophageal squamous cancer.
Journal
Neth J Med 71:69-75 (2013)
Reference
Authors
Kan T, Meltzer SJ
Title
MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
Journal
Reference
Authors
Smith CM, Watson DI, Michael MZ, Hussey DJ
Title
MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
Journal
Reference
Authors
Song S, Ajani JA
Title
The role of microRNAs in cancers of the upper gastrointestinal tract.
Journal
Reference
Authors
Liu WH, Yeh SH, Chen PJ
Title
Role of microRNAs in hepatitis B virus replication and pathogenesis.
Journal
Reference
Authors
Hrasovec S, Glavac D
Title
MicroRNAs as Novel Biomarkers in Colorectal Cancer.
Journal
Reference
Authors
Liu H
Title
MicroRNAs in breast cancer initiation and progression.
Journal
Reference
Authors
Li SD, Zhang JR, Wang YQ, Wan XP
Title
The role of microRNAs in ovarian cancer initiation and progression.
Journal
Reference
Authors
Zabolotneva AA, Zhavoronkov A, Garazha AV, Roumiantsev SA, Buzdin AA
Title
Characteristic patterns of microRNA expression in human bladder cancer.
Journal
Reference
Authors
Saini S, Majid S, Dahiya R
Title
Diet, microRNAs and prostate cancer.
Journal
Related pathway